Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating DP-R212 for hypertension and hypercholesterolemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertension

Drugs mentioned

• DP-R212

Snippet

Sponsor: Alvogen Korea | Conditions: Hypertension, Hypercholesterolemia | Phase 3 | Status: WITHDRAWN